Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

[wonderplugin_pdf src=”https://www.gcbiosciences.co.uk/wp-content/uploads/2019/11/journal.pmed_.0050045.pdf” width=”100%” height=”600px” style=”border:0;”]

/0 Comments/by
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *